Status:

COMPLETED

Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients

Lead Sponsor:

Sun Yat-sen University

Collaborating Sponsors:

Beijing Fresenius Kabi Pharmaceutical Co

Conditions:

Renal Function Disorder

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The prospective, double blind randomized, parallel control, and multi-center clinical trial will evaluate the safety and efficacy of α-keto acid with restricted protein diet on protecting residual ren...

Detailed Description

Residual renal function (RRF) is associated with cardiovascular complication, nutritional status, incidence of peritonitis, and quality of life in peritoneal dialysis (PD) patients. Therefore, RRF is ...

Eligibility Criteria

Inclusion

  • Patients on peritoneal dialysis (PD) at least three month prior to study entry.
  • Subjects of either sex, more than 18 years old, the range of age is 18 to 70 year old.
  • Residual GFR ≥ 3 ml/min/1.73m2.
  • Without α-Keto Acid therapy in recent 4 weeks.
  • Subjects who agree to participate in the study and sign the informed consent.

Exclusion

  • History of peritonitis or other infection within one month.
  • Patients with insufficient dialysis.
  • History of taking drug which may influence amino acid metabolism within one month(glucocorticoid, thyroxin, antithyroid drug, androgens,amino acids,et al).
  • Patients with diseases which contraindicate ketosteril.
  • Cannot control diet according to protocol.
  • Alcohol abuse or drug abuse.
  • Having malignant tumor.
  • History of psychiatric or neuropathic dysfunction.
  • Cardiac failure, with New York Heart Association (NYHA) grade III-IV or history of severe heart and cerebrovascular disease in recent one month(acute stroke, acute heart failure, Lability angina)
  • Serum albumin \< 30g/l.
  • Serum calcium \> 2.8mmol/l.
  • Participation in another clinic trial within last three months

Key Trial Info

Start Date :

March 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT01255020

Start Date

March 1 2010

End Date

December 1 2013

Last Update

May 22 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The 1st Affiliated Hospital, Sun Yet-sen University

Guangzhou, Guangdong, China, 510080

Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients | DecenTrialz